NCT05787873View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

September 21, 2022

Conditions

Healthy

Interventions

DRUG

SIPS-2209-1

QD, PO

DRUG

SIPS-2209-2, SIPS-2209-3

QD, PO

Trial Locations (1)

Unknown

Samik Pharmaceutical Co. Ltd., Incheon

All Listed Sponsors

lead

Samik Pharmaceutical Co. Ltd.

INDUSTRY